← Back to Analyst Consensus 
PRQR Buy
ProQR Therapeutics N.V.
Current Price —
Implied Upside —
Analysts 16
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 2 reiterations from 2 firms
Next Earnings
Nov 5, 2026 (10 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Oct 1, 2026 | Chardan Capital | maintain | Buy → Buy | — | 47% |
| Oct 1, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | — | 44% |
| Aug 20, 2026 | B of A Securities | initiate | — → Buy | — | 53% |
| Jun 29, 2026 | Evercore ISI Group | maintain | Outperform → Outperform | — | 58% |
| Jun 26, 2026 | Jones Trading | maintain | Buy → Buy | — | 50% |
| Jun 26, 2026 | Chardan Capital | maintain | Buy → Buy | — | 47% |
| Apr 9, 2026 | Chardan Capital | maintain | Buy → Buy | — | 47% |
| Nov 4, 2025 | Chardan Capital | maintain | Buy → Buy | $4 | 47% |
| Aug 8, 2025 | Chardan Capital | maintain | Buy → Buy | $4 | 47% |
| Jun 27, 2025 | Cantor Fitzgerald | reiterate | Overweight → Overweight | $8 | 50% |
| Jun 27, 2025 | JMP Securities | reiterate | Market Outperform → Market Outperform | $8 | 53% |
| May 13, 2025 | Oppenheimer | maintain | Outperform → Outperform | $9 | 52% |
| Apr 29, 2025 | Evercore ISI Group | initiate | — → Outperform | $5 | 58% |
| Mar 14, 2025 | Chardan Capital | maintain | Buy → Buy | $4 | 47% |
| Mar 14, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $12 | 44% |
| Feb 12, 2025 | Jones Trading | initiate | — → Buy | $11 | 50% |
| Dec 12, 2024 | JMP Securities | reiterate | Market Outperform → Market Outperform | $8 | 53% |
| Dec 12, 2024 | Chardan Capital | maintain | Buy → Buy | $4 | 47% |
| Dec 12, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $10 | 44% |
| Nov 8, 2024 | HC Wainwright & Co. | maintain | Buy → Buy | $10 | 44% |
| Oct 29, 2024 | Raymond James | upgrade | Outperform → Strong Buy | $14 | 54% |
| May 10, 2024 | Chardan Capital | maintain | Buy → Buy | $2.5 | 47% |
| May 10, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $5 | 44% |
| Apr 18, 2024 | Citigroup | maintain | Neutral → Neutral | $2 | 54% |
| Mar 14, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $5 | 44% |
| Mar 14, 2024 | Chardan Capital | maintain | Buy → Buy | $2.5 | 47% |
| Nov 8, 2023 | Raymond James | maintain | Outperform → Outperform | $4 | 54% |
| Nov 8, 2023 | Chardan Capital | upgrade | Neutral → Buy | $2 | 47% |
| Sep 18, 2023 | Citigroup | maintain | Buy → Buy | $1.8 | 54% |
| Aug 7, 2023 | HC Wainwright & Co. | reiterate | Buy → Buy | $5 | 44% |
| Aug 4, 2023 | Chardan Capital | reiterate | Neutral → Neutral | $2 | 47% |
| May 17, 2023 | Cantor Fitzgerald | maintain | Overweight → Overweight | $4.5 | 50% |
| May 17, 2023 | JMP Securities | reiterate | Market Outperform → Market Outperform | $6 | 53% |
| May 17, 2023 | HC Wainwright & Co. | reiterate | Buy → Buy | $5 | 44% |
| Mar 30, 2023 | JMP Securities | reiterate | — → Market Outperform | $6 | 53% |
| Mar 30, 2023 | HC Wainwright & Co. | maintain | — → Buy | $5 | 44% |
| Dec 23, 2022 | Raymond James | maintain | — → Outperform | $5 | 54% |
| Dec 22, 2022 | Cantor Fitzgerald | upgrade | Neutral → Overweight | $5 | 50% |
| Aug 15, 2022 | HC Wainwright & Co. | maintain | — → Buy | $1.5 | 44% |
| Aug 12, 2022 | Chardan Capital | downgrade | Buy → Neutral | $0 | 47% |
| Aug 12, 2022 | Raymond James | upgrade | Market Perform → Outperform | $2 | 54% |
| May 9, 2022 | HC Wainwright & Co. | maintain | — → Buy | $2 | 44% |
| May 6, 2022 | Chardan Capital | maintain | — → Buy | $2 | 47% |
| Apr 14, 2022 | Chardan Capital | maintain | — → Buy | $2.5 | 47% |
| Apr 14, 2022 | JMP Securities | maintain | — → Market Outperform | $5 | 53% |
| Feb 14, 2022 | Chardan Capital | maintain | — → Buy | $8 | 47% |
| Feb 14, 2022 | JMP Securities | maintain | — → Market Outperform | $8 | 53% |
| Feb 14, 2022 | HC Wainwright & Co. | maintain | — → Buy | $4 | 44% |
| Feb 14, 2022 | Raymond James | downgrade | Strong Buy → Market Perform | $0 | 54% |
| Feb 1, 2022 | Raymond James | initiate | — → Strong Buy | $19 | 54% |
Price Target Trend
Apr 8, 2026 Oct 26, 2026
EPS Estimates
+1q —
0q —
+1y —
0y —
Cross-Platform Signals
No cross-platform signals in the last 90 days